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Abstract
IMPORTANCE Pneumococcal nasopharyngeal carriage is a prerequisite for pneumococcal disease.
Themain transmission route is from toddlers, who commonly carry pneumococci. However, neonatal
pneumococcal disease case reports suggest that vertical pneumococcal transmissionmay also occur.
OBJECTIVE To describe and compare pneumococcal nasopharyngeal carriage and density by infant
mode of delivery in young Fijian infants.
DESIGN, SETTING, AND PARTICIPANTS Annual cross-sectional surveys were performed in Suva,
Fiji, before the introduction of 10-valent pneumococcal conjugate vaccine (PCV10), from September
14 to December 20, 2012, and after PCV10was introduced, from July 11 to November 19, 2013; July
15 to December 9, 2014; and August 13 to November 19, 2015. Caregivers of 2006 infants aged 5 to 8
weeks participated in the surveys. Statistical analysis was performed fromMay 24, 2018, to August
12, 2019.
EXPOSURES Caregivers provided data on infantmode of delivery and demographics via interviewer-
led survey.
MAINOUTCOMES ANDMEASURES Pneumococci in swab samples were detected and quantified
by lytA quantitative polymerase chain reaction with molecular serotyping by microarray.
Pneumococci were categorized as PCV10 or non-PCV10 serotypes.
RESULTS Of the 2006 infants (976 girls and 1030 boys; mean [SD] age, 6.1 [0.02] weeks]), 1742
(86.8%) were born vaginally and 264were born by cesarean delivery. Infants delivered vaginally,
compared with those born by cesarean delivery, had a higher prevalence of overall pneumococcal
nasopharyngeal carriage (470 of 1722 [27.3%; 95% CI, 25.2%-29.4%] vs 47 of 260 [18.1%; 95% CI,
13.6%-23.3%]; P = .002), PCV10 carriage (113 of 1698 [6.7%; 95% CI, 5.5%-7.9%] vs 8 of 256 [3.1%;
95%CI, 1.4%-6.1%]; P = .03), and non-PCV10 carriage (355 of 1698 [20.9%; 95%CI, 19.0%-22.9%]
vs 38 of 256 [14.8%; 95% CI, 10.7%-19.8%]; P = .02), and had higher median densities of overall
pneumococci (4.9 log10 genome equivalents [GE]/mL [interquartile range, 4.8-5.0 log10 GE/mL] vs
4.5 log10 GE/mL [interquartile range, 4.1-4.6 log10 GE/mL]; P = .01) and non-PCV10 pneumococci (4.9
log10 GE/mL [interquartile range, 4.7-5.0 log10 GE/mL] vs 4.4 log10 GE/mL [interquartile range,
4.0-4.7 log10 GE/mL]; P = .01). Vaginal delivery was associated with overall (adjusted odds ratio, 1.57
[95%CI, 1.10-2.23]; P = .01) and non-PCV10 (adjusted odds ratio, 1.49 [95%CI, 1.01-2.20]; P = .04])
pneumococcal nasopharyngeal carriage. Vaginal delivery was not associated with PCV10 carriage
(adjusted odds ratio, 1.67 [95% CI, 0.80-3.51]; P = .17). After adjustment, vaginal delivery was not
associated with density.
(continued)
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Abstract (continued)
CONCLUSIONS ANDRELEVANCE Pneumococcal nasopharyngeal carriage prevalence and density
were higher in infants delivered vaginally compared with those delivered by cesarean birth. After
adjustment, vaginal delivery was associated with pneumococcal carriage. Differences in carriage by
mode of delivery may be due to differential exposure to the vaginal microbiota during delivery and
the effect of intrapartum antibiotics during cesarean delivery on the infant microbiome. Our findings
also raise the hypothesis that vertical transmissionmay contribute to pneumococcal acquisition.
JAMA Network Open. 2019;2(10):e1913650. doi:10.1001/jamanetworkopen.2019.13650
Introduction
Pneumococcal disease is a leading cause of global morbidity andmortality in children younger than 5
years, with the highest burden in low- and middle-income countries (LMICs).1 Of all pneumococcal
meningitis cases in children younger than 5 years, up to 21% occur in infants younger than 2months.2
A review of the causes of community-acquired neonatal sepsis in LMICs reported that the
pneumococcus was isolated in 4.6% (95% CI, 2.1%-7.1%) of cases among infants in the first week of
life.3 Neonatal (infants younger than 28 days) invasive pneumococcal disease (IPD) case fatality rates
are as high as 19% in high-income settings,4 and approximately 50% in LMICs.5 Pneumococcal
transmission during vaginal delivery (vertical transmission) may play a role in neonatal IPD, with
maternal pneumococcal vaginal colonization present in 25 of 43 reported neonatal IPD cases
(58.1%).6-21 Only 2 studies have published rates of pneumococcal vaginal carriage. In France,
pneumococcal isolates were found in 0.66% of 1064 vaginal swabs, and in England, pneumococcal
isolates were detected in 0.03% of 15 000 high vaginal, cervical, urethral, and genital swabs.16,22 To
our knowledge, there are no published studies reporting the prevalence of pneumococcal vaginal
carriage in pregnant women from LMICs, despite pneumococci being a common cause of
neonatal sepsis.3
Nasopharyngeal pneumococcal carriage is associated with an increased risk of pneumococcal
disease, and high pneumococcal nasopharyngeal load (density) is associated with severe
pneumococcal pneumonia.23,24 In LMICs, the first acquisition of pneumococci occurs early in life. In
Papua New Guinea, 59% of infants carry pneumococci by 30 days of age.25 Factors associated with
pneumococcal carriage in young infants from LMICs remain unclear. Although contact with toddlers
and children is a risk factor for pneumococcal carriage via horizontal transmission, maternal vaginal
colonization, prolonged rupture of membranes, and premature delivery may be risk factors for
vertical transmission.26-29 To our knowledge, no published studies describe infant pneumococcal
carriage and density by infant mode of delivery or document the association of mode of delivery with
carriage.
A previous study in Fiji described the association of 10-valent pneumococcal conjugate vaccine
(PCV10) with pneumococcal carriage, which included infants aged 5 to 8 weeks who were not
vaccinated for PCV10.30 This study aims to compare the prevalence and density of pneumococcal
carriage by infant mode of delivery and to describe any associations between vaginal delivery and
pneumococcal carriage and density in very young unvaccinated Fijian infants. We hypothesize that in
this population, pneumococcal carriage and density differ by mode of delivery, and that vaginal
delivery is associated with pneumococcal carriage.
Methods
Fiji is a middle-income nation in the South Pacific Ocean. The population comprises 56.8%
indigenous iTaukei individuals and 37.8% Fijian of Indian descent individuals. This study was
undertaken in the Suva-Nausori corridor in the central division of Fiji, where approximately one-third
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of Fijian individuals live.31 Fiji introduced PCV10 in October 2012 as a 3 + 0 schedule, given at 6, 10,
and 14 weeks of age, with no catch-up campaign. National coverage of the third dose of PCV10 was
84.9% 1 year after introduction, 84.9% 2 years after introduction, and 89.0% 3 years after
introduction.32-34 This study was conducted according to protocols reviewed and approved by the
Fiji National Research Ethics Review Committee and the University of Melbourne Human Research
Ethics Subcommittee. Study staff discussed the study with parents and guardians (caregivers), who
completedwritten informed consent prior to any study procedures. Participants and caregivers were
offered no incentive to participate. This study followed the Strengthening the Reporting of
Observational Studies in Epidemiology (STROBE) reporting guideline.
The study design has been described previously.30 Briefly, annual cross-sectional community-
based nasopharyngeal carriage surveys were conducted before the introduction of PCV10
(September 14 to December 20, 2012) and after the introduction of PCV10 (July 11 to November 19,
2013; July 15 to December 9, 2014; and August 13 to November 19, 2015).30 We used purposive
convenience sampling to ensure that the sample represented the iTaukei to Fijian of Indian descent
ethnicity ratio (3:2), and rural to urban residential location ratio (1:1), as these were considered likely
to be associated with pneumococcal carriage.35
Participants
Infants aged 5 to 8 weeks were recruited while attendingmaternal and child health clinics for routine
immunization at the 2 largest health centers in Suva. Inclusion criteria were age and themother
having lived in the area for 3 months or more at the time of survey. We excluded infants with an
axillary temperature higher than 37.0°C or who had received any prior PCV10 doses. The sample size
was calculated to answer the primary research question regarding the direct association of PCV10
with pneumococcal nasopharyngeal carriage.30 For convenience, this study used the same sample.
Data Collection
Fieldworkers interviewed caregivers via questionnaire to obtain individual-level infant
characteristics, including ethnicity (iTaukei or Fijian of Indian descent), sex, residential location,
antibiotic use in the 2 weeks preceding the survey, infant mode of delivery, current breastfeeding
status, exposure to household cigarette smoke, weekly family income, number of children younger
than 5 years living in the household, and symptoms of an upper respiratory tract infection. Caregivers
reported ethnicity according to investigator defined options. Ethnicity was assessed in the broader
PCV10 evaluation, as it is known to be associated with pneumococcal carriage in Fiji.35
Nasopharyngeal samples were collected using flocked nylon swabs (FLOQSwabs; COPAN
Diagnostics Inc), placed in skimmilk tryptone glucose glycerol media, and stored according to
standardmethods.36 Samples were analyzed at theMurdoch Children’s Research Institute,
Melbourne, Australia. The detection and density of pneumococci were determined by real-time
quantitative polymerase chain reaction with primers and probes targeting the lytA gene (GenBank
933669), and genomic DNA from a reference isolate as a standard.37 Molecular serotyping of
pneumococci was conducted bymicroarray, as described previously.38
Overall pneumococcal carriage was defined as the detection of any pneumococcus by
quantitative polymerase chain reaction. Carriage of PCV10was defined as detection of PCV10
serotypes (1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, and 23F). Non-PCV10 carriage was defined as detection of
serotypes not included in PCV10, including nonencapsulated pneumococci. Serotypes 15B and 15C
were reported as 15B/C, as these serotypes can interconvert.39 Serotype 11Awas identified as 11F-like,
as reported previously.40
Detection of PCV10 and non-PCV10 serotypes from the same sample was recorded as positive
for PCV10 and non-PCV10 carriage. Carriage of multiple serotypes was defined as detection of 2 or
more serotypes from the same sample. Pneumococcal density was reported in genome equivalents
(GE) per milliliter. Serotype-specific carriage was defined as detection of individual serotypes,
including nonencapsulated pneumococci.
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Double entry and validation of participant characteristic data were performed in EpiData,
version 3.1 (EpiData). Pneumococcal data were entered into Microsoft Excel 2013 (Microsoft Corp).
Participant characteristics and pneumococcal data were merged and cleaned in Stata, version 15.1
(StataCorp).
Statistical Analysis
Statistical analyses were performed fromMay 24, 2018, to August 12, 2019, in Stata, version 15.1.
Participant characteristics were summarized by counts and percentages, or means and SDs. Carriage
data were reported as counts and percentages with 95% CIs. Pneumococcal densities were log10
transformed, and reported asmedian log10 GE permilliliter with interquartile range (IQR). Categorical
variables were compared by the χ2 test. Means of continuous variables were compared using the t
test andmedians of continuous variables were compared using theMann-Whitney test. Description
of multiple-serotype carriage and analyses of serotype-specific carriage and pneumococcal density
were restricted to pneumococcal carriers. We used the Fisher exact test to compare serotype-
specific carriage prevalence by infant mode of delivery. All P values were from 2-sided tests and
results were deemed statistically significant at P < .05.
Logistic and quantile regressionmodels were built to determine the association of infant mode
of delivery with overall, PCV10, and non-PCV10 pneumococcal carriage and density. Multivariable
models adjusted for potential confounders (survey year, residential location, low family income, and
2 children younger than 5 years living in the household) selected a priori using a directed acyclic
graph (eFigure and eAppendix in the Supplement). Correlation between exposures included in
regressionmodels was assessed using Pearson r.
Although ethnicity is associated with pneumococcal carriage in Fiji, it was not included in
multivariable models, as infant mode of delivery does not differ by ethnicity in Fiji.41 The associations
between infant mode of delivery with carriage were reported as odds ratios (ORs) and the
associations between infant mode of delivery with density were reported as differences in medians,
with 95% CIs and P values.
Results
Demographics
Of the 2006 infants, 1742 (86.8%) were born vaginally and 264were born by cesarean delivery.
Participant mean (SD) age was 6.1 (0.02) weeks (Table 1).42 The distribution by sex was
approximately equal (976 girls and 1030 boys). However, more infants born vaginally were female,
compared with those born by cesarean delivery (865 [49.7%] vs 111 [42.0%]; P = .02). Few
participants used antibiotics in the 2 weeks preceding the survey (42 of 2005 [2.1%]). The
percentage of infants living in a rural location was lower in those born vaginally compared with those
born by cesarean delivery (851 [48.9%] vs 176 [66.7%]; P < .001). A lower percentage of infants
delivered vaginally had low family income compared with those born by cesarean delivery (845 of
1697 [49.8%] vs 149 of 257 [58.0%]; P = .01). A higher percentage of infants born vaginally livedwith
children younger than 5 years compared with infants born by cesarean delivery (797 [45.8%] vs 90
[34.1%]; P < .001). The percentage of vaginal and cesarean delivered participants differed annually
(Table 1).42
Pneumococcal Carriage Prevalence andMedianDensity
Twenty nasopharyngeal swab samples from infants delivered vaginally and 4 from infants born by
cesarean delivery were excluded from analysis owing to insufficient volume, sample loss, or labeling
errors. Twenty-eight pneumococcal-positive samples were excluded from serotyping owing to
technical issues. Infants born vaginally had a higher prevalence of overall pneumococci (470 of 1722
[27.3%; 95% CI, 25.2%-29.4%] vs 47 of 260 [18.1%; 95% CI, 13.6%-23.3%]; P = .002), PCV10
pneumococci (113 of 1698 [6.7%; 95%CI, 5.5%-7.9%] vs 8 of 256 [3.1%; 95%CI, 1.4%-6.1%]; P = .03),
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and non-PCV10 pneumococci (355 of 1698 [20.9%; 95%CI, 19.0%-22.9%] vs 38 of 256 [14.8%; 95%
CI, 10.7%-19.8%]; P = .02) compared with infants born by cesarean delivery (Table 1).42 Among
pneumococcal carriers, the prevalence of multiple-serotype carriage was similar by infant mode of
delivery. Vaginally delivered infants, compared with those born by cesarean delivery, had higher
median density of overall pneumococci (4.9 log10 GE/mL [IQR, 4.8-5.0 log10 GE/mL] vs 4.5 log10
GE/mL [IQR, 4.1-4.6 log10 GE/mL]; P = .01) and non-PCV10 pneumococci (4.9 log10 GE/mL [IQR
4.7-5.0 log10 GE/mL] vs 4.4 log10 GE/mL [IQR 4.0-4.7 log10 GE/mL]; P = .01) (Table 1).
42
Table 1. Characteristics of Fijian Infants Aged 5 to 8Weeks in 4 Annual Pneumococcal Nasopharyngeal
Carriage Surveys
Characteristics
Infants, No./Total No. (%)
P ValueaTotal
Delivery
Vaginal Cesarean
Age, mean (SD), wk 6.1 (0.02) 6.1 (0.02) 6.1 (0.04) .76
Female sex 976/2006 (48.7) 865/1742 (49.7) 111/264 (42.0) .02
Ethnicity
Fijian of Indian descent 796/2006 (39.7) 681/1742 (39.1) 115/264 (43.6)
.23iTaukei 1202/2006 (59.9) 1053/1742 (60.4) 149/264 (56.4)
Other 8/2006 (0.4) 8/1742 (0.5) 0
Breastfeeding at time of survey 1857/2005 (92.6) 1609/1741 (92.4) 248/264 (93.9) .38
Symptoms of URTI 311/2005 (15.5) 260/1742 (14.9) 51/264 (19.3) .07
Antibiotic use in past 2 wk 42/2005 (2.1) 35/1741 (2.0) 7/264 (2.7) .50
Residential location
Rural 1027/2006 (51.2) 851/1742 (48.9) 176/264 (66.7)
<.001
Urban 979/2006 (48.8) 891/1742 (51.1) 88/264 (33.3)
Low family incomeb 994/1954c (50.9) 845/1697 (49.8) 149/257 (58.0) .01
Exposure to household
cigarette smoke
1011/2006 (50.4) 871/1742 (50.0) 140/264 (53.0) .36
≥2 Children aged <5 y in household 887/2006 (44.2) 797/1742 (45.8) 90/264 (34.1) <.001
Survey year
Before introduction of PCV10 499/2006 (24.9) 456/1742 (26.2) 43/264 (16.3)
<.001
After introduction of PCV10
1 y 510/2006 (25.4) 457/1742 (26.2) 53/264 (20.1)
2 y 500/2006 (24.9) 405/1742 (23.3) 95/264 (36.0)
3 y 497/2006 (24.8) 424/1742 (24.3) 73/264 (27.7)
Pneumococcal carriage, No./total
No. (%) [95% CI, %]
Overalld 517/1982 (26.1)
[24.2-28.1]
470/1722 (27.3)
[25.2-29.4]
47/260 (18.1)
[13.6-23.3]
.002
PCV10 serotypee 121/1954 (6.2)
[5.2-7.4]
113/1698 (6.7)
[5.5-7.9]
8/256 (3.1)
[1.4-6.1]
.03
Non-PCV10 serotypef 393/1954 (20.1)
[18.4-22.0]
355/1698 (20.9)
[19.0-22.9]
38/256 (14.8)
[10.7-19.8]
.02
Multiple-serotype carriageg 79/489 (16.2
[13.0-19.7])
72/446 (16.1
[12.9-19.9])
7/43 (16.3
[6.8-30.7])
.98
Pneumococcal densityg
Overall
No. 516 469 47
.01
log10 GE/mL, median (IQR) 4.9 (4.7-5.0) 4.9 (4.8-5.0) 4.5 (4.1-4.6)
PCV10 serotype
No. 121 113 8
.39
log10 GE/mL, median (IQR) 5.0 (4.6-5.1) 5.0 (4.7-5.2) 4.5 (3.6-5.9)
Non-PCV10 serotype
No. 393 355 38
.01
log10 GE/mL, median (IQR) 4.8 (4.6-5.0) 4.9 (4.7-5.0) 4.4 (4.0-4.7)
Abbreviations: GE, genome equivalents; IQR,
interquartile range; PCV10, 10-valent pneumococcal
conjugate vaccine; URTI, upper respiratory tract
infection.
a Determined from χ2 for categorical variables and
from t test or Mann-Whitney test for continuous
variables, as appropriate.
b Weekly family income below the basic needs poverty
line (<FJ$175 per week).42
c Family income data wasmissing for 52
participants (2.6%).
d Any pneumococci, including nonencapsulated
pneumococci.
e Pneumococci included in PCV10 (serotypes 1, 4, 5,
6B, 7F, 9V, 14, 18C, 19F, and 23F).
f Pneumococcal serotypes not included in PCV10,
including nonencapsulated pneumococci.
g Only includes participants who were pneumococcal
carriers, PCV10 serotype carriers, or non-PCV10
serotypes carriers.
JAMANetworkOpen | Global Health Comparing Pneumococcal Nasopharyngeal Carriage by Infant Mode of Delivery in Fiji
JAMA Network Open. 2019;2(10):e1913650. doi:10.1001/jamanetworkopen.2019.13650 (Reprinted) October 18, 2019 5/14
Downloaded From: https://jamanetwork.com/ by a London Sch of Hygiene & Tropical Medicine User  on 11/11/2019
Serotype-Specific Carriage
The Figure displays serotype-specific carriage prevalence by infant mode of delivery. Of the
serotypes carried by cesarean-born infants, 12.5% (3 of 24) were PCV10 serotype and 20.8% (5 of
24) were PCV13 serotype. For infants delivered vaginally, 17.6% (9 of 51) were PCV10 serotype and
21.6% (11 of 51) were PCV13 serotype. We detected PCV10 serotypes 6B, 19F, and 23F from infants
born by either mode of delivery, while PCV10 serotypes 1, 4, 7F, 9V, 14, and 18C were detected from
infants born only by vaginal delivery. Serotypes 4 and 18C represented 9.3% (11 of 118) of PCV10
serotypes found in such infants. Non-PCV10 serotypes 6A, 6C, 6D, 7C, 10B, 11A, 13, 15B/C, 16F, 17F,
19A, 21, 22F, 24B, 33B, 34, 35B, 38, and nonencapsulated lineages NT2, NT2/NT3b, and NT3b were
Figure. Pneumococcal Serotype-Specific Prevalence Among 2006 Fijian Infants, by InfantMode of Delivery
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The total sample in the study was 2006: 1742 infants
delivered vaginally and 264 born via cesarean delivery.
A total of 24 nasopharyngeal swab samples were
unable to be processed for pneumococcal detection:
20 from infants born vaginally and 4 from infants born
by cesarean delivery. For pneumococcal results, only
1722 vaginally delivered infants and 260 born via
cesarean delivery had results for carriage. PCV10
indicates 10-valent pneumococcal conjugate vaccine.
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detected in infants born by either mode of delivery. An additional 21 non-PCV10 serotypes were
detected exclusively from infants born vaginally, including 3, 7B, 8, 10A, 12F, 15A, 18A, 19B, 20, 20B,
23A, 23B, 24F, 29, 31, 33A, 33F, 35A, 35F, 39, and the nonencapsulated lineage NT4b. NT2,
NT2/NT3b, NT3b, and NT4 are genetic variants of nonencapsulated pneumococci identified by
microarray.43 Of the 21 11A serotypes identified, 19 were genetic variants identified bymicroarray as
11F-like.40 Serotype-specific carriage prevalence did not differ by infant mode of delivery (eTable 1 in
the Supplement).
Association Between InfantMode of Delivery and Pneumococcal Carriage
Table 2 shows the association of infantmode of deliverywith pneumococcal carriage (overall, PCV10,
and non-PCV10). Vaginal delivery was positively associated with overall pneumococcal
nasopharyngeal carriage (adjusted OR [aOR], 1.57 [95% CI, 1.10-2.23]; P = .01) and non-PCV10
carriage (aOR, 1.49 [95% CI, 1.01-2.20]; P = .04). Vaginal delivery was not associated with PCV10
carriage (aOR, 1.67 [95% CI, 0.80-3.51]; P = .17). There was no evidence of correlation between
exposure variables included in regressionmodels (eTable 2 in the Supplement).
Association Between InfantMode of Delivery and Pneumococcal Density
eTable 3 in the Supplement shows unadjusted and adjusted differences in median density of overall,
PCV10, and non-PCV10 pneumococci.We found no association between infantmode of delivery and
pneumococcal density (overall, PCV10, and non-PCV10).
Discussion
This study describes pneumococcal carriage by infant mode of delivery. Vaginal delivery was
positively associated with overall and non-PCV10 carriage. The prevalence of overall, PCV10, and
non-PCV10 carriage was greater in infants delivered vaginally, compared with those delivered by
cesarean birth. Possible reasons for these differences in pneumococcal carriage by infant mode of
delivery include vertical transmission of pneumococci, reduced acquisition of pneumococci owing to
routine intrapartum administration of antibiotics administered during cesarean delivery for
postoperative wound prophylaxis, and/or the association that infant mode of delivery may have with
the infant microbiome.
We found a positive association between vaginal delivery and pneumococcal carriage, raising
the hypothesis of a potential vertical component to pneumococcal acquisition for very young infants.
Contact with toddlers is a risk factor for pneumococcal carriage via horizontal transmission.27-29
However, we found the positive association between vaginal delivery and pneumococcal carriage
remained after adjustment for the potential of horizontal transmission from young children living in
the same household. This finding suggests that vertical transmissionmay be a route for acquisition of
nasopharyngeal pneumococci in very young infants, which has been proposed previously.6,7
Maternal vaginal colonization and subsequent transmission during delivery to infants is documented
for other bacteria.44 The pneumococcus is not considered a commensal of the human vaginal tract,
as the prevalence of pneumococcal vaginal colonization is very low.16,22 However, transient
cervicovaginal colonization can occur, and vertical transmission of pneumococci may occur via
premature or prolonged rupture of membranes, chorioamnionitis, or perinatal maternal
pneumococcal disease.6,16,22,26 Case reports from high-income countries of neonatal IPD, as well as
maternal pneumococcal vaginal colonization, suggest vertical transmission of pneumococci during
delivery.6,7 Despite high rates of early infant IPD in LMICs, we were unable to find studies from LMICs
onmaternal vaginal pneumococcal carriage rates. We did not collect maternal vaginal swabs or
nasopharyngeal swabs from children living in participants’ households, so we were unable to
determine the route of transmission.
The association found between vaginal delivery and infant carriage may also be explained by
receipt of maternal intrapartum antibiotics for postoperative wound prophylaxis for cesarean
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delivery and neonatal sepsis. A double-blind, placebo-controlled randomized trial of azithromycin
given to women in labor in Gambia found substantial reductions in prevalence of pneumococcal
carriage in infants aged 28 days born to womenwho received azithromycin, compared with those
born to womenwho received placebo (prevalence ratio, 0.67 [95% CI, 0.53-0.83]; P < .001).45
Table 2. Associations Between InfantMode of Delivery and Pneumococcal Carriage in Fijian Infants Aged 5 to 8
Weeks, in 4 Annual Pneumococcal Carriage Surveys
Characteristics
Unadjusted Model Adjusted Modela
OR (95% CI) P Value OR (95% CI) P Value
Overall Pneumococcal Carriage (n = 1982)b
Infant mode of delivery
Cesarean 1 [Reference]
.002
1 [Reference]
.01
Vaginal 1.70 (1.22-2.37) 1.57 (1.10-2.23)
Survey year
Before introduction of PCV10 1 [Reference]
<.001
1 [Reference]
<.001
After introduction of PCV10
1 y 0.71 (0.54-0.95) 0.94 (0.69-1.27)
2 y 0.43 (0.31-0.58) 0.65 (0.46-0.91)
3 y 1.26 (0.96-1.65) 1.48 (1.11-1.96)
Residential location
Rural 1 [Reference]
.28
1 [Reference]
.44
Urban 1.12 (0.91-1.36) 1.09 (0.88-1.35)
Low family incomec 1.36 (1.11-1.67) .004 1.32 (1.06-1.64) .01
≥2 Children aged <5 y in household 2.28 (1.86-2.80) .01 1.99 (1.60-2.48) <.001
PCV10 Serotype Pneumococcal Carriage (n = 1954)d
Infant mode of delivery
Cesarean 1 [Reference]
.03
1 [Reference]
.17
Vaginal 2.21 (1.07-4.58) 1.67 (0.80-3.51)
Survey year
Before introduction of PCV10 1 [Reference]
.002
1 [Reference]
.03
After introduction of PCV10
1 y 0.60 (0.37-0.96) 0.65 (0.39-1.07)
2 y 0.34 (0.19-0.60) 0.41 (0.22-0.75)
3 y 0.59 (0.36-0.96) 0.63 (0.38-1.04)
Residential location
Rural 1 [Reference]
.006
1 [Reference]
.02
Urban 1.70 (1.16-2.47) 1.64 (1.10-2.44)
Low family incomec 1.06 (0.73-1.54) .77 0.99 (0.67-1.48) .98
≥2 Children aged <5 y in household 1.94 (1.33-2.81) .001 1.56 (1.04-2.32) .03
Non-PCV10 Serotype Pneumococcal Carriage (n = 1954)e
Infant mode of delivery
Cesarean 1 [Reference]
.03
1 [Reference]
.04
Vaginal 1.52 (1.05-2.18) 1.49 (1.01-2.20)
Survey year
Before introduction of PCV10 1 [Reference]
<.001
1 [Reference]
<.001
After introduction of PCV10
1 y 0.81 (0.59-1.12) 1.14 (0.81-1.61)
2 y 0.52 (0.37-0.74) 0.85 (0.58-1.25)
3 y 1.65 (1.23-2.22) 2.00 (1.45-2.73)
Residential location
Rural 1 [Reference]
.71
1 [Reference]
.49
Urban 0.96 (0.77-1.20) 0.92 (0.72-1.16)
Low family incomec 1.37 (1.09-1.71) .007 1.36 (1.07-1.73) .01
≥2 Children aged <5 y in household 2.39 (1.91-3.00) <.001 2.25 (1.76-2.88) <.001
Abbreviations: OR, odds ratio; PCV10, 10-valent
pneumococcal conjugate vaccine.
a Variables adjusted for were survey year, residential
location, low family income, and 2 or more children
younger than 5 years living in the household.
b Any pneumococci, including nonencapsulated
pneumococci.
c Weekly family income below the basic needs poverty
line (<FJ$175 per week).42
d Pneumococci included in PCV10 (serotypes 1, 4, 5,
6B, 7F, 9V, 14, 18C, 19F, and 23F).
e Pneumococcal serotypes not included in PCV10,
including nonencapsulated pneumococci.
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However, perinatal azithromycin use is uncommon. In Fiji, flucloxacillin and amoxycillin are the usual
antibiotics of choice for surgical wound and neonatal sepsis prophylaxis. We did not record which
women received antibiotics, and were unable to stratify analyses by receipt of antibiotics during
delivery. Nevertheless, maternal antibiotics may have affected infants born to women undergoing
cesarean delivery either transplacentally and/or through breast milk ingestion after delivery, which
may have reduced pneumococcal acquisition by vertical and/or horizontal routes.46-48
The differences we found in carriage bymode of delivery may be owing to the differential
effects of mode of delivery on the development of the infant microbiome. The infant microbiome
develops different profiles after vaginal or cesarean delivery, owing to exposure to maternal vaginal
or environmental flora and the disruptive effects of intrapartum prophylactic antibiotics,48,49 which
may affect pneumococcal carriage in very young infants. A longitudinal study of Dutch infants found
that, after cesarean delivery, there was a delay in the development of the infant microbiome, with
lower relative abundance of pneumococci up to 3 months of age, compared with those born
vaginally.50
Exposure to environmental flora and intrapartum antibiotics during cesarean delivery may have
mediated both the association between vaginal delivery and pneumococcal carriage and the number
of unique serotypes detected, through their association withmaternal and infant microbiomes. We
found more pneumococcal serotypes from infants born vaginally compared with those delivered by
cesarean birth. More important, serotypes 4 and 18C were found exclusively in infants delivered
vaginally, and represented 9.3% of PCV10 serotypes found in such infants. This finding is important,
as these serotypes are not included in the PCV10 vaccine (Pneumosil) currently undergoing phase
3 clinical trials in India.51 AWorld Health Organization review of the age distribution of pneumococcal
disease found that, despite some uncertainty about the rates of pneumococcal infection in very
young infants, 32% to 79% of serotypes causing IPD in infants younger than 2months would be
covered by PCV10 or PCV13.2 We found a lower percentage covered by PCV10 or PCV13, as our study
was conducted up to 3 years after the introduction of PCV10. Nevertheless, despite evidence of PCV
indirect effects on very young unvaccinated infants,30 many such infants will remain at risk of IPD
due to nonvaccine serotypes.3,52 The difference found in number of serotypes by mode of delivery
may be owing to the higher number of participants delivered vaginally compared with cesarean
delivery (1722 vs 260, after excluding nasopharyngeal swab samples owing to insufficient volume,
sample loss, or labeling errors), which may lend itself to a greater number of serotypes being
detected in swab samples from vaginally born infants.
We found a positive association between infant mode of delivery and overall and non-PCV10
carriage. The 95% CI observed for PCV10 carriage, which crossed the null value, may be owing to the
small number of infants carrying PCV10 serotypes, likely reflecting the timing of our study in relation
to the introduction of PCV10 in Fiji. A previous study reported that PCV10 carriage declined among
unvaccinated infants age 5 to 8 weeks after the introduction of PCV10, suggesting indirect
protection.30 As such, the 95% CI estimated for the association between infant mode of delivery and
PCV10 carriage may be explained by reduced rates of PCV10 carriage owing to herd immunity, and
the small number of cesarean delivered infants who were PCV10 carriers (n = 8).
We found that carriage of multiple serotypes was uncommon and similar by infant mode of
delivery. Few studies have examined rates of multiple-serotype carriage in this age group or used
molecular serotypingmethods to do so, and to our knowledge, no other study has compared the
prevalence of multiple-serotype carriage by infant mode of delivery.
Although data are limited, estimates suggest the pneumococcus remains a significant pathogen
with regard to neonatal sepsis in LMICs.53 A systematic review of the global burden of neonatal IPD
estimated the pooled incidence in less-developed countries to be 16 (95% CI, 3.9-65.6) per 100000
live births and in themore developed countries to be 41 (95% CI, 29.1-58.1) per 100000.53 These
counterintuitive estimates are likely driven by differential case ascertainment by setting.53 A review
of the cause of community-acquired neonatal sepsis in LMICs isolated Streptococcus pneumoniae
from 4.6% (95% CI, 2.1%-7.1%) of infants younger than 7 days and 5.2% (95% CI, 4.2%-6.3%) of
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infants ages 8 to 59 days.3 A study on the cause of serious infection in young infants in low-income
countries found 8% of bacteremia in infants younger than 7 days to be due to pneumococci and
10.2% of bacteremia aged 8 to 29 days to be due to pneumococci.5 The same study found 38.5% of
meningitis cases in infants aged 7 to 29 days to be due to pneumococcus. A global review of
pneumococcal disease found that 21% of all pneumococcal meningitis cases in children younger than
5 years occurred in infants younger than 2months.2 In addition, several cases of neonatal IPD,
including sepsis, with pneumococci isolated frommaternal genital tracts have been reported.6,7 Our
findings suggest that, in Fiji, pneumococcus may be an important cause of young infant infection
and should be considered in cases of infection in such a population in Fiji and other LMICs.
Limitations
There were limitations to our study in addition to thosementioned earlier. First, generalizability may
be limited to unvaccinated Fijian infants living in Suva. Because of the cross-sectional design, this
study is unable to assume causality between infant mode of delivery and pneumococcal carriage.
However, delivery precedes nasopharyngeal sampling, such that temporality regarding infant mode
of delivery and carriage may be assumed. Data supporting an association between infant mode of
delivery and pneumococcal carriage may be confounded by unmeasured clinical factors, such as
prematurity.26 The possibility of chance findings owing tomultiple testing exists. However, this study
was conducted in a tropical setting in the Asian Pacific, where infant pneumococcal carriage rates are
relatively high, and sufficient participants were delivered via cesarean birth to achieve a sample size
sufficient to undertake this analysis. In addition, nasopharyngeal swabs were collected and
processed in accordance withWorld Health Organization guidelines.36 Pneumococci were detected
and quantified using sensitive and quantitative molecular methods, and few data were missing.38
Conclusions
This study found that infant mode of delivery is positively associated with pneumococcal carriage.
Our observations may be owing to differences in early pneumococcal carriage through differential
exposure to the vaginal microbiota during delivery and the association of intrapartum antibiotics
during cesarean delivery with the infant microbiome. Our results generate the hypothesis that
vertical transmissionmay occur. Our findings have important public health and clinical implications
for young infants in LMICs. As pneumococcal carriage rates are far higher in young infants in LMICs
than those in high-income countries, rates of pneumococcal sepsis in young infants are likely
considerable.2 Among neonates in LMICs, the burden of pneumococcal carriage and IPD is largely
unknown, but, where reported, are substantial.2 Invasive pneumococcal disease should be
considered in cases of neonatal sepsis in LMICs,3 as herd protection in unvaccinated infants cannot
be assumed as current PCV formulations may not provide adequate coverage for many IPD
serotypes.
In post-PCV settings, and with increasing consideration of reduced-dose PCV schedules,
monitoring pneumococcal transmission will be central to pneumococcal disease control, particularly
in the most vulnerable age groups.54 To our knowledge, there are no data on the prevalence of
pneumococcal vaginal colonization in LMICs. Further research is required to investigate the
possibility of vertical transmission during delivery, maternal pneumococcal vaginal colonization,
antibiotic use during labor, the effect of mode of delivery on the infant microbiome (as are studies on
neonatal carriage in other LMICs), and enhanced neonatal IPD surveillance.
ARTICLE INFORMATION
Accepted for Publication: August 16, 2019.
Published:October 18, 2019. doi:10.1001/jamanetworkopen.2019.13650
JAMANetworkOpen | Global Health Comparing Pneumococcal Nasopharyngeal Carriage by Infant Mode of Delivery in Fiji
JAMA Network Open. 2019;2(10):e1913650. doi:10.1001/jamanetworkopen.2019.13650 (Reprinted) October 18, 2019 10/14
Downloaded From: https://jamanetwork.com/ by a London Sch of Hygiene & Tropical Medicine User  on 11/11/2019
OpenAccess: This is an open access article distributed under the terms of the CC-BY License. © 2019Neal EFG et al.
JAMA Network Open.
Corresponding Author: Eleanor Frances Georgina Neal, MPH, Infection and Immunity, Murdoch Children’s
Research Institute, Royal Children’s Hospital, Flemington Road, Parkville, VIC 3052, Australia (eleanor.neal@
rch.org.au).
Author Affiliations: Infection and Immunity, Murdoch Children’s Research Institute, Royal Children’s Hospital,
Parkville, Victoria, Australia (Neal, Nguyen, Dunne, Reyburn, Satzke, Mulholland, Russell); Department of
Paediatrics, The University of Melbourne, Parkville, Victoria, Australia (Neal, Nguyen, Dunne, Satzke, Mulholland,
Russell); Centre for International Child Health, Department of Paediatrics, The University of Melbourne, Parkville,
Victoria, Australia (Neal, Russell); Ministry of Health andMedical Services, Suva, Fiji (Ratu, Matanitobua, Kama,
Devi, Tikoduadua, Rafai); Fiji Health Sector Support Program, Suva, Fiji (Jenkins); College of Medicine Nursing and
Health Sciences, Fiji National University, Suva, Fiji (Kado); Telethon Kids Institute, University ofWestern Australia,
Nedlands, Western Australia, Australia (Kado); Department of Microbiology and Immunology, Peter Doherty
Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria, Australia (Satzke);
Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United
Kingdom (Mulholland).
Author Contributions:MsNeal and Dr Russell had full access to all the data in the study and take responsibility for
the integrity of the data and the accuracy of the data analysis.
Concept and design:Neal, Nguyen, Ratu, Matanitobua, Kama, Jenkins, Kado, Rafai, Satzke, Russell.
Acquisition, analysis, or interpretation of data:Neal, Nguyen, Dunne, Reyburn, Kama, Devi, Tikoduadua, Satzke,
Mulholland, Russell.
Drafting of the manuscript:Neal.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis:Neal.
Obtained funding: Satzke, Russell.
Administrative, technical, or material support:Neal, Ratu, Matanitobua, Dunne, Reyburn, Kama, Devi, Jenkins,
Kado, Rafai, Satzke, Russell.
Supervision:Nguyen, Tikoduadua, Satzke, Mulholland, Russell.
Conflict of Interest Disclosures: Drs Nguyen, Dunne, Satzke, and Mulholland reported being investigators on a
clinical research collaboration with Pfizer investigating the effect of pneumococcal conjugate vaccine on adult
pneumonia in Mongolia. Dr Satzke reported receiving grants from the Bill & Melinda Gates Foundation during the
conduct of the study. Dr Russell reported receiving grants from the Bill & Melinda Gates Foundation and the
Department of Foreign Affairs and Trade, Australia, during the conduct of the study. No other disclosures were
reported.
Funding/Support: This work was supported by grants OPP1126272 and OPP1084341from the Bill &Melinda Gates
Foundation, the Victorian Government’s Operational Infrastructure Support Project, and the Department of
Foreign Affairs and Trade of the Australian Government, the Fiji Health Sector Support Program (FHSSP). The
FHSSPwas implemented by Abt JTA on behalf of the Australian Government. Dr Russell held a National Health and
ResearchMedical Council (NHMRC) Early Career Fellowship and NHMRC TRIP Fellowship; Dr Satzke holds an
NHMRC Career Development Fellowship and a Veski InspiringWomen Fellowship; andMs Neal holds an Australian
Government Research Training Program Scholarship.
Role of the Funder/Sponsor: The funding sources had no role in the design and conduct of the study; collection,
management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and
decision to submit themanuscript for publication.
Additional Contributions:We acknowledge the significant contributions made by the study participants and
families in Fiji, the staff in Fiji, and the staff at the Murdoch Children’s Research Institute. Shi Cheng, MPH,
Department of Hospital Infection Control, Beijing Tiantan Hospital Affiliated to Capital Medical University; Sister
Seruwaia Young, BPHN, Fiji Ministry of Health and Medical Services; Casey Pell, BBiomedSc, Murdoch Children’s
Research Institute; Monica Nation, MEpi, Murdoch Children’s Research Institute; and Jayne Manning, PhD,
Murdoch Children’s Research Institute, assisted with data collection. They were not compensated for their
contributions beyond their salaries.
REFERENCES
1. Wahl B, O’Brien KL, Greenbaum A, et al. Burden of Streptococcus pneumoniae andHaemophilus influenzae type
b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15. Lancet
Glob Health. 2018;6(7):e744-e757. doi:10.1016/S2214-109X(18)30247-X
JAMANetworkOpen | Global Health Comparing Pneumococcal Nasopharyngeal Carriage by Infant Mode of Delivery in Fiji
JAMA Network Open. 2019;2(10):e1913650. doi:10.1001/jamanetworkopen.2019.13650 (Reprinted) October 18, 2019 11/14
Downloaded From: https://jamanetwork.com/ by a London Sch of Hygiene & Tropical Medicine User  on 11/11/2019
2. Russell FM, Sanderson C, Temple B, Mulholland K. Global Review of the Distribution of Pneumococcal Disease by
Age and Region. Geneva, Switzerland: World Health Organization; 2011.
3. Waters D, Jawad I, Ahmad A, et al. Aetiology of community-acquired neonatal sepsis in low andmiddle income
countries. J Glob Health. 2011;1(2):154-170.
4. Okike IO, Johnson AP, Henderson KL, et al; neoMen Study Group. Incidence, etiology, and outcome of bacterial
meningitis in infants aged <90 days in the United kingdom and Republic of Ireland: prospective, enhanced,
national population-based surveillance. Clin Infect Dis. 2014;59(10):e150-e157. doi:10.1093/cid/ciu514
5. TheWHO Young Infants Study Group. Bacterial etiology of serious infections in young infants in developing
countries: results of a multicenter study. Pediatr Infect Dis J. 1999;18(10)(suppl):S17-S22.
6. Alsubaie SS. Early-onset neonatal pneumococcal infection: a problemdeservingmore recognition: a case report
and review of the literature. Infect Dis Clin Pract. 2019;27(2):68-72. doi:10.1097/IPC.0000000000000696
7. Fothy JF, Vetter S, Iñigo A, Gil J, Pérez JL, Hervás JA. Early-onset Streptococcus pneumoniae neonatal sepsis and
meningitis in the 13-valent vaccine era. Pediatr Infect Dis J. 2013;32(11):1299-1300. doi:10.1097/INF.
0b013e31829ebeea
8. WeintraubMI, Otto RN. Pneumococcal meningitis and endophthalmitis in a newborn. JAMA. 1972;219(13):
1763-1764. doi:10.1001/jama.219.13.1763
9. Rhodes PG, Burry VF, Hall RT, Cox R. Pneumococcal septicemia andmeningitis in the neonate. J Pediatr. 1975;
86(4):593-595. doi:10.1016/S0022-3476(75)80159-4
10. Bortolussi R, Thompson TR, Ferrieri P. Early-onset pneumococcal sepsis in newborn infants. Pediatrics. 1977;
60(3):352-355.
11. Tarpay MM, Turbeville DF, Krous HF. Fatal streptococcus pneumoniae type III sepsis in mother and infant. Am J
Obstet Gynecol. 1980;136(2):257. doi:10.1016/0002-9378(80)90608-0
12. Naylor JC, Wagner KR. Neonatal sepsis due to Streptococcus pneumoniae. CMAJ. 1985;133(10):1019-1020.
13. Andreu A, Genover E, Coira A, Farrán I. Antepartum infection as a result of Streptococcus pneumoniae and
sepsis in neonate. Am J Obstet Gynecol. 1989;161(5):1424-1425. doi:10.1016/0002-9378(89)90724-2
14. Geelen SP, Gerards LJ, Fleer A. Pneumococcal septicemia in the newborn: a report on seven cases and a review
of the literature. J Perinat Med. 1990;18(2):125-129. doi:10.1515/jpme.1990.18.2.125
15. Wright ED, Lortan JE, Perinpanayagam RM. Early-onset neonatal pneumococcal sepsis in siblings. J Infect.
1990;20(1):59-63. doi:10.1016/S0163-4453(90)92368-U
16. Primhak RA, Tanner MS, Spencer RC. Pneumococcal infection in the newborn. Arch Dis Child. 1993;69(3 Spec
No):317-318. doi:10.1136/adc.69.3_Spec_No.317
17. Simpson JM, Patel JS, Ispahani P. Streptococcus pneumoniae invasive disease in the neonatal period: an
increasing problem? Eur J Pediatr. 1995;154(7):563-566. doi:10.1007/BF02074835
18. McDonald LC, Bryant K, Snyder J. Peripartum transmission of penicillin-resistant Streptococcus pneumoniae.
J Clin Microbiol. 2003;41(5):2258-2260. doi:10.1128/JCM.41.5.2258-2260.2003
19. SakranW, Valinsky L, Koren A, Bor N, Yishai R, Colodner R. Early onset of neonatal Streptococcus pneumoniae
bacteremia and septic arthritis. Clin Pediatr (Phila). 2004;43(6):579-581. doi:10.1177/000992280404300613
20. Sallam A, Paes B. Streptococcus pneumoniae: an old bug with significant maternal–newborn implications. Am
J Perinatol. 2004;21(8):491-495. doi:10.1055/s-2004-835967
21. Karabayir N, Hatipoglu N, Adal E, Sanli K. A rare case of sepsis in newborn: Streptococcus pneumoniae
septicemia. Arch Gynecol Obstet. 2010;282(5):591-592. doi:10.1007/s00404-010-1489-y
22. Darbás H, Boyer G. Isolation of Streptococcus pneumoniae from genital samples: discussion of its pathogenic
role [in French]. Pathol Biol (Paris). 1987;35(2):177-180.
23. Simell B, Auranen K, Käyhty H, Goldblatt D, Dagan R, O’Brien KL; Pneumococcal Carriage Group. The
fundamental link between pneumococcal carriage and disease. Expert Rev Vaccines. 2012;11(7):841-855. doi:10.
1586/erv.12.53
24. Vu HT, Yoshida LM, Suzuki M, et al. Association between nasopharyngeal load of Streptococcus pneumoniae,
viral coinfection, and radiologically confirmed pneumonia in Vietnamese children. Pediatr Infect Dis J. 2011;30
(1):11-18. doi:10.1097/INF.0b013e3181f111a2
25. Aho C, Michael A, Yoannes M, et al; Neonatal Pneumococcal Conjugate Vaccine Trial Study Team. Limited
impact of neonatal or early infant schedules of 7-valent pneumococcal conjugate vaccination on nasopharyngeal
carriage of Streptococcus pneumoniae in Papua New Guinean children: a randomized controlled trial. Vaccine Rep.
2016;6:36-43. doi:10.1016/j.vacrep.2016.08.002
JAMANetworkOpen | Global Health Comparing Pneumococcal Nasopharyngeal Carriage by Infant Mode of Delivery in Fiji
JAMA Network Open. 2019;2(10):e1913650. doi:10.1001/jamanetworkopen.2019.13650 (Reprinted) October 18, 2019 12/14
Downloaded From: https://jamanetwork.com/ by a London Sch of Hygiene & Tropical Medicine User  on 11/11/2019
26. Hoffman JA, Mason EO, Schutze GE, et al. Streptococcus pneumoniae infections in the neonate. Pediatrics.
2003;112(5):1095-1102. doi:10.1542/peds.112.5.1095
27. Althouse BM, Hammitt LL, Grant L, et al. Identifying transmission routes of Streptococcus pneumoniae and
sources of acquisitions in high transmission communities. Epidemiol Infect. 2017;145(13):2750-2758. doi:10.1017/
S095026881700125X
28. Weinberger DM, Pitzer VE, Regev-Yochay G, Givon-Lavi N, Dagan R. Association between the decline in
pneumococcal disease in unimmunized adults and vaccine-derived protection against colonization in toddlers and
preschool-aged children. Am J Epidemiol. 2019;188(1):160-168. doi:10.1093/aje/kwy219
29. Neal EFG, Flasche S, Ratu T, et al. Ethnicity andmixing with older children are risk factors for vaccine-type
pneumococcal carriage post 10-valent pneumococcal conjugate vaccine introduction in Fiji: a cross-sectional
study. Paper presented at: 11th International Symposium on Pneumococci and Pneumococcal Diseases; April 18,
2018; Melbourne, Australia.
30. Dunne EM, Satzke C, Ratu FT, et al. Effect of ten-valent pneumococcal conjugate vaccine introduction on
pneumococcal carriage in Fiji: results from four annual cross-sectional carriage surveys. Lancet Glob Health. 2018;
6(12):e1375-e1385. doi:10.1016/S2214-109X(18)30383-8
31. Government of Fiji, Fiji Islands Bureau of Statistics. 2017 Population and Housing Census. Suva, Fiji:
Government of Fiji; 2018.
32. Ministry of Health. Annual report 2013. https://www.health.gov.fj/wp-content/uploads/2018/03/Annual-
Report-2013.pdf. Accessed November 11, 2018.
33. Ministry of Health &Medical Services. Ministry of Health &Medical Services annual report 2014. https://www.
health.gov.fj/PDFs/Annual Report/Annual Report 2014.pdf. Accessed November 11, 2018.
34. Ministry of Health &Medical Services. Annual report 2015. http://www.parliament.gov.fj/wp-content/uploads/
2017/02/MoHMS-AR-2015.pdf. Accessed November 11, 2018.
35. Russell FM, Carapetis JR, Ketaiwai S, et al. Pneumococcal nasopharyngeal carriage and patterns of penicillin
resistance in young children in Fiji. Ann Trop Paediatr. 2006;26(3):187-197. doi:10.1179/146532806X120273
36. Satzke C, Turner P, Virolainen-Julkunen A, et al; WHO Pneumococcal CarriageWorking Group. Standard
method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from
theWorld Health Organization Pneumococcal CarriageWorking Group. Vaccine. 2013;32(1):165-179. doi:10.1016/j.
vaccine.2013.08.062
37. CarvalhoMdaG, Tondella ML, McCaustland K, et al. Evaluation and improvement of real-time PCR assays
targeting lytA, ply, and psaA genes for detection of pneumococcal DNA. J Clin Microbiol. 2007;45(8):2460-2466.
doi:10.1128/JCM.02498-06
38. Satzke C, Dunne EM, Porter BD, Klugman KP, Mulholland EK; PneuCarriage project group. The PneuCarriage
Project: a multi-centre comparative study to identify the best serotyping methods for examining pneumococcal
carriage in vaccine evaluation studies. PLoS Med. 2015;12(11):e1001903. doi:10.1371/journal.pmed.1001903
39. van Selm S, van Cann LM, KolkmanMAB, van der Zeijst BAM, van Putten JPM. Genetic basis for the structural
difference between Streptococcus pneumoniae serotype 15B and 15C capsular polysaccharides. Infect Immun.
2003;71(11):6192-6198. doi:10.1128/IAI.71.11.6192-6198.2003
40. Manna S, Ortika BD, Dunne EM, et al. A novel genetic variant of Streptococcus pneumoniae serotype 11A
discovered in Fiji. Clin Microbiol Infect. 2018;24(4):428.e1-428.e7. doi:10.1016/j.cmi.2017.06.031
41. RamN, Nusair PW, Fong J, MohammadnezhadM, Andajari S. Prevalence and characteristics of caesarean
section (CS) among pregnant womenwho delivered at the Colonial War Memorial Hospital (CWMH) Suva, Fiji,
2016. Pacific J Rep Health. 2018;1(7):384-389. doi:10.18313/pjrh.2018.906
42. NarseyW, Raikoti T, Waqavonovono E. Preliminary report: poverty and household incomes in Fiji in 2008-09
(based on the 2008-09 Household Income and Expenditure Survey). http://www.spc.int/nmdi/Reports/Fiji_HIES_
2008-09.pdf. Accessed April 26, 2019.
43. Salter SJ, Hinds J, Gould KA, et al. Variation at the capsule locus, cps, of mistyped and non-typable
Streptococcus pneumoniae isolates.Microbiology. 2012;158(pt 6):1560-1569. doi:10.1099/mic.0.056580-0
44. Seale AC, Bianchi-Jassir F, Russell NJ, et al. Estimates of the burden of group B streptococcal disease
worldwide for pregnant women, stillbirths, and children. Clin Infect Dis. 2017;65(suppl 2):S200-S219. doi:10.1093/
cid/cix664
45. Roca A, Oluwalana C, Bojang A, et al. Oral azithromycin given during labour decreases bacterial carriage in the
mothers and their offspring: a double-blind randomized trial. Clin Microbiol Infect. 2016;22(6):565.e1-565.e9. doi:
10.1016/j.cmi.2016.03.005
JAMANetworkOpen | Global Health Comparing Pneumococcal Nasopharyngeal Carriage by Infant Mode of Delivery in Fiji
JAMA Network Open. 2019;2(10):e1913650. doi:10.1001/jamanetworkopen.2019.13650 (Reprinted) October 18, 2019 13/14
Downloaded From: https://jamanetwork.com/ by a London Sch of Hygiene & Tropical Medicine User  on 11/11/2019
46. Pacifici GM. Placental transfer of antibiotics administered to themother: a review. Int J Clin Pharmacol Ther.
2006;44(2):57-63. doi:10.5414/CPP44057
47. Mathew JL. Effect of maternal antibiotics on breast feeding infants. Postgrad Med J. 2004;80(942):196-200.
doi:10.1136/pgmj.2003.011973
48. Gallacher DJ, Kotecha S. Respiratory microbiome of new-born infants. Front Pediatr. 2016;4:10. doi:10.3389/
fped.2016.00010
49. Dominguez-Bello MG, Costello EK, Contreras M, et al. Delivery mode shapes the acquisition and structure of
the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A. 2010;107(26):
11971-11975. doi:10.1073/pnas.1002601107
50. Bosch AATM, Levin E, van HoutenMA, et al. Development of upper respiratory tract microbiota in infancy is
affected bymode of delivery. EBioMedicine. 2016;9(C):336-345. doi:10.1016/j.ebiom.2016.05.031
51. US National Library of Medicine, National Institutes of Health. Phase 3 study of 10-valent pneumococcal
conjugate vaccine (PNEUMOSIL) administered in a 2+1 schedule to healthy infants. https://clinicaltrials.gov/ct2/
show/record/NCT03896477. Accessed April 24, 2019.
52. Mount V, Burton C, Jackson C, Heffernan H, Best E. Neonatal invasive pneumococcal disease: New Zealand
experience in the era of pneumococcal vaccination. Aust N Z J Obstet Gynaecol. 2017;57(3):280-285. doi:10.1111/
ajo.12512
53. Billings ME, Deloria-Knoll M, O’Brien KL. Global burden of neonatal invasive pneumococcal disease:
a systematic review andmeta-analysis. Pediatr Infect Dis J. 2016;35(2):172-179. doi:10.1097/INF.
0000000000000955
54. Flasche S, Van Hoek AJ, Goldblatt D, et al. The potential for reducing the number of pneumococcal conjugate
vaccine doses while sustaining herd immunity in high-income countries. PLoS Med. 2015;12(6):e1001839. doi:10.
1371/journal.pmed.1001839
SUPPLEMENT.
eFigure.Directed Acyclic Graph to Select Factors for Statistical Adjustment
eAppendix.Dagity Code for eFigure, Directed Acyclic Graph to Identify a Minimal Set of Factors for Statistical
Adjustment
eTable 1. Comparison of Serotype-Specific Carriage in Fijian Infants Aged 5 to 8Weeks, by Infant Mode of Delivery
eTable 2. Correlation Between Exposures Included in RegressionModels Assessed Using Pearson r
eTable 3. Associations Between Infant Mode of Delivery and Pneumococcal Carriage Density in Fijian Infants Aged
5 to 8Weeks, in 4 Annual Pneumococcal Carriage Surveys
eReferences
JAMANetworkOpen | Global Health Comparing Pneumococcal Nasopharyngeal Carriage by Infant Mode of Delivery in Fiji
JAMA Network Open. 2019;2(10):e1913650. doi:10.1001/jamanetworkopen.2019.13650 (Reprinted) October 18, 2019 14/14
Downloaded From: https://jamanetwork.com/ by a London Sch of Hygiene & Tropical Medicine User  on 11/11/2019
